sheng bai
Botanicalexperimental
Clinical trial activity
2 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Jan 15, 2018 (NCT03413358)
Timeline
2020s
- Jan 1, 2024
Earliest Phase 2 Sponsor(trial)
Indications
Studied for
Mechanism of action
- UnclearUnclear
Unclear unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06706752 | Phase 2 | Dec 31, 2024 | Sutter Health |
| NCT03413358 | N/A | Jan 15, 2018 | Beijing Yijiayi Medicine Techonoloy Co., Ltd., China Academy of Chinese Medical Sciences, Hubei Mon Yan Pharmaceutical Co., Ltd |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Beijing Yijiayi Medicine Techonoloy Co., Ltd. | For profit | 1 | 1 | 1 | 2018 |
| China Academy of Chinese Medical Sciences | Academic/Hospital | 1 | 0 | 1 | 2018 |
| Hubei Mon Yan Pharmaceutical Co., Ltd | Government | 1 | 0 | 1 | 2018 |
| Sutter Health | Academic/Hospital | 1 | 1 | 1 | 2024 |
4 organizations
Page 1 / 1